From Biohealth Investor
Biotechnology
LA JOLLA PHARMA [LJPC] +43.10%
AURIGA LABORATORIES [ARGA.OB] +19.05%
BIONOVO INC [BNVI.OB] +15.76%
VION PHARM INC [VION] +12.58%
RENOVIS INC [RNVS] +8.07%
Diagnostic Substances
NYMOX PHARM CORP [NYMX] +14.45%
GENE LOGIC INC [GLGC] +6.97%
REMOTEMDX INC [RMDX.OB] +5.75%
INTERLEUKIN GENETICS [ILI] +4.58%
COLEY PHARMACEUTICAL [COLY] +4.53%
Drug Delivery
DELCATH SYSTEMS INC [DCTH] +2.90%
BIOVAIL CORP [BVF] +1.96%
PETMED EXPRESS INC [PETS] +1.60%
NOVEN PHARMACEUTIC [NOVN] +1.26%
QUIGLEY CORP THE [QGLY] +1.05%
Drug Manufacturers
AMARIN CORP PLC AD [AMRN] +13.61%
CORTEX PHARM INC [COR] +9.89%
EXEGENICS INC [EXEG.OB] +6.61%
DUSA PHARM INC [DUSA] +4.35%
SPECTRUM PHARMA INC [SPPI] +3.57%
Medical Appliances & Equipment
MEDIS TECH LTD [MDTL] +7.07%
BSD MEDICAL CORP [BSM] +5.35%
LANGER INC [GAIT] +4.28%
ACCURAY INCORPORATED [ARAY] +4.06%
CANDELA CP [CLZR] +3.74%
Medical Instruments & Supplies
CRYOCOR, INC. [CRYO] +10.66%
CARDICA, INC. [CRDC] +6.05%
ENCISION INC [ECI] +5.25%
CARDIAC SCIENCE CORP [CSCX] +5.01%
COOPER COS INC [COO] +4.62%
Medical Laboratories & Research
MEDASORB TECHNOLOGS [MSBT.OB] +3.45%
ARRAY BIOPHARMA IN [ARRY] +3.19%
NEOGENOMICS INC [NGNM.OB] +1.86%
MEDTOX SCIENTFIC INC [MTOX] +1.49%
BIO-REFERENCE LAB [BRLI] +1.45%
http://www.biohealthinvestor.com/
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
